» Articles » PMID: 37709531

Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies

Abstract

A methodology for determining tau PET thresholds is needed to confidently detect early tau deposition. We compared multiple threshold-determining methods in participants who underwent either F-flortaucipir or F-MK-6240 PET scans. F-flortaucipir ( = 798) and F-MK-6240 ( = 216) scans were processed and sampled to obtain regional SUV ratios. Subsamples of the cohorts were based on participant diagnosis, age, amyloid-β status (positive or negative), and neurodegeneration status (positive or negative), creating older-adult (age ≥ 55 y) cognitively unimpaired (amyloid-β-negative, neurodegeneration-negative) and cognitively impaired (mild cognitive impairment/Alzheimer disease, amyloid-β-positive, neurodegeneration-positive) groups, and then were further subsampled via matching to reduce significant differences in diagnostic prevalence, age, and Mini-Mental State Examination score. We used the biostatistical estimation of tau threshold hallmarks (BETTH) algorithm to determine sensitivity and specificity in 6 composite regions. Parametric double receiver operating characteristic analysis yielded the greatest joint sensitivity in 5 of the 6 regions, whereas hierarchic clustering, gaussian mixture modeling, and k-means clustering all yielded perfect joint specificity (2.00) in all regions. When F-flortaucipir and F-MK-6240 are used, Alzheimer disease-related tau status is best assessed using 2 thresholds, a sensitivity one based on parametric double receiver operating characteristic analysis and a specificity one based on gaussian mixture modeling, delimiting an uncertainty zone indicating participants who may require further evaluation.

Citing Articles

Tau Imaging: Use and Implementation in New Diagnostic and Therapeutic Paradigms for Alzheimer's Disease.

Gogola A, Lopresti B, Minhas D, Lopez O, Cohen A, Villemagne V Geriatrics (Basel). 2025; 10(1).

PMID: 39997526 PMC: 11855481. DOI: 10.3390/geriatrics10010027.


The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer's disease and tau burden.

Huang K, Hsiao I, Huang C, Huang C, Chang H, Huang S Alzheimers Dement. 2025; 21(1):e14297.

PMID: 39777990 PMC: 11772711. DOI: 10.1002/alz.14297.


Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.

Zeng X, Lafferty T, Sehrawat A, Chen Y, Ferreira P, Bellaver B Mol Neurodegener. 2024; 19(1):68.

PMID: 39385222 PMC: 11465638. DOI: 10.1186/s13024-024-00753-5.


Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies.

Gogola A, Cohen A, Snitz B, Minhas D, Tudorascu D, Ikonomovic M J Alzheimers Dis. 2024; 100(s1):S75-S92.

PMID: 39121123 PMC: 11776372. DOI: 10.3233/JAD-240543.


Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.

Zeng X, Lafferty T, Sehrawat A, Chen Y, Ferreira P, Bellaver B medRxiv. 2024; .

PMID: 38947065 PMC: 11213097. DOI: 10.1101/2024.06.15.24308975.


References
1.
van der Kall L, Truong T, Burnham S, Dore V, Mulligan R, Bozinovski S . Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals. Neurology. 2020; 96(5):e662-e670. PMC: 7884996. DOI: 10.1212/WNL.0000000000011222. View

2.
Braak H, Braak E . Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995; 16(3):271-8; discussion 278-84. DOI: 10.1016/0197-4580(95)00021-6. View

3.
Greiner M, Sohr D, Gobel P . A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods. 1995; 185(1):123-32. DOI: 10.1016/0022-1759(95)00121-p. View

4.
Marquie M, Normandin M, Vanderburg C, Costantino I, Bien E, Rycyna L . Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol. 2015; 78(5):787-800. PMC: 4900162. DOI: 10.1002/ana.24517. View

5.
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12:77. PMC: 3068975. DOI: 10.1186/1471-2105-12-77. View